{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:49:05Z","timestamp":1790153345698,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR13-21"],"award-info":[{"award-number":["W.OR13-21"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0620-3","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T03:11:55Z","timestamp":1541560315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Satellite cells maintain regenerative capacity but fail to repair disease-associated muscle damage in mice with Pompe disease"],"prefix":"10.1186","volume":"6","author":[{"given":"Gerben J.","family":"Schaaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom J. M.","family":"van Gestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn L. M.","family":"in \u2018t Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Boomaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Tarallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Cardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans T.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7042-2482","authenticated-orcid":false,"given":"W. W. M. Pim","family":"Pijnappel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,7]]},"reference":[{"key":"620_CR1","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/hmg\/9.17.2507","volume":"9","author":"A Ahmad","year":"2000","unstructured":"Ahmad A, Brinson M, Hodges BL, Chamberlain JS, Amalfitano A (2000) Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy. Hum Mol Genet 9:2507\u20132515. \n                    https:\/\/doi.org\/10.1093\/hmg\/9.17.2507","journal-title":"Hum Mol Genet"},{"key":"620_CR2","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s00415-011-6293-5","volume":"259","author":"C Angelini","year":"2012","unstructured":"Angelini C, Semplicini C, Ravaglia S, Bembi B, Servidei S, Pegoraro E et al (2012) Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol. 259:952\u2013958","journal-title":"J Neurol."},{"key":"620_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00401-017-1754-2","volume":"134","author":"M Attia","year":"2017","unstructured":"Attia M, Maurer M, Robinet M, Le Grand F, Fadel E, Le Panse R et al (2017) Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration. Acta Neuropathol 134:869\u2013888","journal-title":"Acta Neuropathol"},{"key":"620_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10545-010-9201-8","volume":"33","author":"B Bembi","year":"2010","unstructured":"Bembi B, Pisa FE, Confalonieri M, Ciana G, Fiumara A, Parini R et al (2010) Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis 33:727\u2013735","journal-title":"J Inherit Metab Dis"},{"key":"620_CR5","first-page":"85","volume-title":"International Review of Cell and Molecular Biology","author":"AJ Bergsma","year":"2018","unstructured":"Bergsma AJ, van der Wal E, Broeders M, van der Ploeg AT, Pim Pijnappel WWM (2018) Alternative Splicing in Genetic Diseases: Improved Diagnosis and Novel Treatment Options. In: International Review of Cell and Molecular Biology, vol 335, pp 85\u2013141"},{"key":"620_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/hmg\/7.1.53","volume":"7","author":"AGA Bijvoet","year":"1998","unstructured":"Bijvoet AGA, Van De Kamp EHM, Kroos MA, Ding JH, Yang BZ, Visser P et al (1998) Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease. Hum Mol Genet 7:53\u201362","journal-title":"Hum Mol Genet"},{"key":"620_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.stem.2012.04.001","volume":"10","author":"AS Brack","year":"2012","unstructured":"Brack AS, Rando TA (2012) Tissue-specific stem cells: Lessons from the skeletal muscle satellite cell. Cell Stem Cell 10:504\u2013514","journal-title":"Cell Stem Cell"},{"key":"620_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0960-8966(99)00093-0","volume":"10","author":"S Decary","year":"2000","unstructured":"Decary S, Ben Hamida C, Mouly V, Barbet JP, Hentati F, Butler-Browne GS (2000) Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul Disord 10:113\u2013120","journal-title":"Neuromuscul Disord"},{"key":"620_CR9","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/NEN.0b013e3181aa31c2","volume":"68","author":"I Desguerre","year":"2009","unstructured":"Desguerre I, Mayer M, Leturcq F, Barbet J-P, Gherardi RK, Christov C (2009) Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol 68:762\u2013773","journal-title":"J Neuropathol Exp Neurol"},{"key":"620_CR10","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Wang YX, von Maltzahn J, Pasut A, Bentzinger CF, Brun CE et al (2015) Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med 21:1455\u20131463. \n                    https:\/\/doi.org\/10.1038\/nm.3990","journal-title":"Nat Med"},{"key":"620_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.apmr.2014.11.020","volume":"96","author":"MM Favejee","year":"2015","unstructured":"Favejee MM, van den Berg LE, Kruijshaar ME, Wens SC, Praet SF, Pim Pijnappel WW et al (2015) Exercise training in adults with Pompe disease: the effects on pain, fatigue, and functioning. Arch Phys Med Rehabil 96:817\u2013822 doi:S0003-9993(14)01284-2 [pii]10.1016\/j.apmr.2014.11.020","journal-title":"Arch Phys Med Rehabil"},{"key":"620_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/ana.20807","volume":"59","author":"T Fukuda","year":"2006","unstructured":"Fukuda T, Ewan L, Bauer M, Mattaliano RJ, Zaal K, Ralston E et al (2006b) Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol 59:700\u2013708","journal-title":"Ann Neurol"},{"key":"620_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4161\/auto.2984","volume":"2","author":"T Fukuda","year":"2006","unstructured":"Fukuda T, Roberts A, Ahearn M, Zaal K, Ralston E, Plotz PH et al (2006a) Autophagy and lysosomes in Pompe disease. Autophagy 2:318\u2013320","journal-title":"Autophagy"},{"issue":"15089","key":"620_CR14","first-page":"1","volume":"8","author":"F Gatto","year":"2017","unstructured":"Gatto F, Rossi B, Tarallo A, Polishchuk E, Polishchuk R, Carrella A et al (2017) AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease. Sci Rep 8(15089):1\u201312","journal-title":"Sci Rep"},{"key":"620_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF02889849","volume":"45","author":"JL Griffin","year":"1984","unstructured":"Griffin JL (1984) Infantile acid maltase deficiency. I. Muscle fiber destruction after lysosomal rupture. Virchows Arch B Cell Pathol Incl Mol Pathol 45:23\u201336","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"620_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cmet.2011.12.001","volume":"15","author":"A Guerci","year":"2012","unstructured":"Guerci A, Lahoute C, H\u00e9brard S, Collard L, Graindorge D, Favier M et al (2012) Srf-dependent paracrine signals produced by myofibers control satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 15:25\u201337","journal-title":"Cell Metab"},{"key":"620_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1212\/01.wnl.0000198776.53007.2c","volume":"66","author":"MLC Hagemans","year":"2006","unstructured":"Hagemans MLC, Hop WJC, Van Doom PA, Reuser AJJ, Van Der Ploeg AT (2006) Course of disability and respiratory function in untreated late-onset Pompe disease. Neurology 66:581\u2013583","journal-title":"Neurology"},{"key":"620_CR18","doi-asserted-by":"publisher","first-page":"e0147198","DOI":"10.1371\/journal.pone.0147198","volume":"11","author":"D Hardy","year":"2016","unstructured":"Hardy D, Besnard A, Latil M, Jouvion G, Briand D, Th\u00e9penier C et al (2016) Comparative Study of Injury Models for Studying Muscle Regeneration in Mice. PLoS One 11:e0147198","journal-title":"PLoS One"},{"key":"620_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cell.2013.02.053","volume":"153","author":"JE Heredia","year":"2013","unstructured":"Heredia JE, Mukundan L, Chen FM, Mueller AA, Deo RC, Locksley RM et al (2013) Type 2 innate signals stimulate fibro\/adipogenic progenitors to facilitate muscle regeneration. Cell 153:376\u2013388","journal-title":"Cell"},{"key":"620_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/ncb2015","volume":"12","author":"AW Joe","year":"2010","unstructured":"Joe AW, Yi L, Natarajan A, Le Grand F, So L, Wang J et al (2010) Muscle injury activates resident fibro\/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 12:153\u2013163. \n                    https:\/\/doi.org\/10.1038\/ncb2015","journal-title":"Nat Cell Biol"},{"key":"620_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL et al (2007) Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 68:99\u2013109","journal-title":"Neurology"},{"key":"620_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00441-010-0976-6","volume":"340","author":"M Kottlors","year":"2010","unstructured":"Kottlors M, Kirschner J (2010) Elevated satellite cell number in Duchenne muscular dystrophy. Cell Tissue Res 340:541\u2013548","journal-title":"Cell Tissue Res"},{"key":"620_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1083\/jcb.200508001","volume":"172","author":"S Kuang","year":"2006","unstructured":"Kuang S, Charg\u00e9 SB, Seale P, Huh M, Rudnicki MA (2006) Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J Cell Biol 172:103\u2013113. \n                    https:\/\/doi.org\/10.1083\/jcb.200508001","journal-title":"J Cell Biol"},{"key":"620_CR24","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1212\/WNL.0000000000004711","volume":"89","author":"E Kuperus","year":"2017","unstructured":"Kuperus E, Kruijshaar ME, Wens SCA, de Vries JM, Favejee MM, van der Meijden JC et al (2017) Long-term benefit of enzyme replacement therapy in Pompe disease. Neurology. 89:2365\u20132373. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000004711","journal-title":"Neurology."},{"key":"620_CR25","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1242\/dev.067595","volume":"138","author":"C Lepper","year":"2011","unstructured":"Lepper C, Partridge TA, Fan C-M (2011) An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 138:3639\u20133646","journal-title":"Development"},{"key":"620_CR26","first-page":"185","volume":"6","author":"BC Leutholtz","year":"1996","unstructured":"Leutholtz BC, Ripoll I (1996) The effects of exercise on a patient with severe acid maltasae deficiency. Eur J Phys Med Rehabil 6:185\u2013187","journal-title":"Eur J Phys Med Rehabil"},{"issue":"2","key":"620_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF00319609","volume":"269","author":"J Lexell","year":"1992","unstructured":"Lexell J, Jarvis J, Downham D, Salmons S (1992) Quantitative morphology of stimulation-induced damage in rabbit fast-twitch skeletal muscles. Cell Tissue Res 269(2):195\u2013204","journal-title":"Cell Tissue Res"},{"key":"620_CR28","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/nprot.2015.110","volume":"10","author":"L Liu","year":"2015","unstructured":"Liu L, Cheung TH, Charville GW, Rando TA (2015) Isolation of skeletal muscle stem cells by fluorescence-activated cell sorting. Nat Protoc 10:1612\u20131624. \n                    https:\/\/doi.org\/10.1038\/nprot.2015.110","journal-title":"Nat Protoc"},{"key":"620_CR29","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1093\/hmg\/ddu194","volume":"23","author":"A Lu","year":"2014","unstructured":"Lu A, Poddar M, Tang Y, Proto JD, Sohn J, Mu X et al (2014) Rapid depletion of muscle progenitor cells in dystrophic mdx\/utrophin-\/-mice. Hum Mol Genet 23:4786\u20134800","journal-title":"Hum Mol Genet"},{"key":"620_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.9.2.493","volume":"9","author":"A Mauro","year":"1961","unstructured":"Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9:493\u2013495","journal-title":"J Biophys Biochem Cytol"},{"key":"620_CR31","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1016\/j.yexcr.2010.05.014","volume":"316","author":"JE Morgan","year":"2010","unstructured":"Morgan JE, Zammit PS (2010) Direct effects of the pathogenic mutation on satellite cell function in muscular dystrophy. Exp Cell Res 316:3100\u20133108","journal-title":"Exp Cell Res"},{"key":"620_CR32","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/cdd.2012.52","volume":"19","author":"AC Nascimbeni","year":"2012","unstructured":"Nascimbeni AC, Fanin M, Masiero E, Angelini C, Sandri M (2012) The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII). Cell Death and Differentiation 19:1698\u20131708","journal-title":"Cell Death and Differentiation"},{"key":"620_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ymgme.2017.06.007","volume":"22","author":"C Papadopoulos","year":"2017","unstructured":"Papadopoulos C, Orlikowski D, Prigent H, Lacour A, Tard C, Furby A et al (2017) Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme(R)) in 12 patients with advanced late-onset Pompe disease. Mol Genet Metab. 22:80\u201385","journal-title":"Mol Genet Metab."},{"key":"620_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1530\/EC-17-0042","volume":"6","author":"N Preisler","year":"2017","unstructured":"Preisler N, Lafor\u00eat P, Madsen KL, Husu E, Vissing CR, Hedermann G et al (2017) Skeletal muscle metabolism during prolonged exercise in pompe disease. Endocr Connect 6:384\u2013394","journal-title":"Endocr Connect"},{"key":"620_CR35","doi-asserted-by":"publisher","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","volume":"273","author":"N Raben","year":"1998","unstructured":"Raben N, Nagaraju K, Lee E, Kessler P, Byrne B, Lee L et al (1998) Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem 273:19086\u201319092. \n                    https:\/\/doi.org\/10.1074\/jbc.273.30.19086","journal-title":"J Biol Chem"},{"key":"620_CR36","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4161\/auto.4591","volume":"3","author":"N Raben","year":"2007","unstructured":"Raben N, Takikita S, Pittis MG, Bembi B, Marie SKN, Roberts A et al (2007) Deconstructing pompe disease by analyzing single muscle fibers: To see a world in a grain of sand. Autophagy 3:546\u2013552","journal-title":"Autophagy"},{"key":"620_CR37","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10545-012-9451-8","volume":"35","author":"C Regnery","year":"2012","unstructured":"Regnery C, Kornblum C, Hanisch F, Vielhaber S, Strigl-Pill N, Grunert B et al (2012) 36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy. J Inherit Metab Dis 35:837\u2013845","journal-title":"J Inherit Metab Dis"},{"key":"620_CR38","unstructured":"Reuser A, Hirschhorn R, Kroos MA. Pompe Disease: Glycogen Storage Disease Type II, Acid \u03b1-Glucosidase (Acid Maltase) Deficiency. In: The online Metabolic and Molecular Bases of Inherited Disease. David Valle, MD, Editor-in-Chief, Arthur L. Beaudet, MD, Editor, Bert Vogelstein, MD, Editor, Kenneth W. Kinzler, Ph.D., Editor, Stylianos E. Antonarakis, MD, D.Sc., Editor, Andrea Ballabio, M. 2018. p. 1\u201372."},{"key":"620_CR39","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","volume":"143","author":"A Sacco","year":"2010","unstructured":"Sacco A, Mourkioti F, Tran R, Choi J, Llewellyn M, Kraft P et al (2010) Short telomeres and stem cell exhaustion model duchenne muscular dystrophy in mdx\/mTR mice. Cell 143:1059\u20131071","journal-title":"Cell"},{"key":"620_CR40","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1242\/dev.067587","volume":"138","author":"R Sambasivan","year":"2011","unstructured":"Sambasivan R, Yao R, Kissenpfennig A, Van Wittenberghe L, Paldi A, Gayraud-Morel B et al (2011) Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development 138:3647\u20133656. \n                    https:\/\/doi.org\/10.1242\/dev.067587","journal-title":"Development"},{"key":"620_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-015-0243-x","volume":"3","author":"GJ Schaaf","year":"2015","unstructured":"Schaaf GJ, van Gestel TJ, Brusse E, Verdijk RM, de Coo IF, van Doorn PA et al (2015) Lack of robust satellite cell activation and muscle regeneration during the progression of Pompe disease. Acta Neuropathol Commun 3:1\u201311","journal-title":"Acta Neuropathol Commun"},{"key":"620_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13395-015-0046-6","volume":"5","author":"S Schiaffino","year":"2015","unstructured":"Schiaffino S, Rossi AC, Smerdu V, Leinwand LA, Reggiani C (2015) Developmental myosins: expression patterns and functional significance. Skelet Muscle 5:22. \n                    https:\/\/doi.org\/10.1186\/s13395-015-0046-6","journal-title":"Skelet Muscle"},{"key":"620_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0092-8674(00)00066-0","volume":"102","author":"P Seale","year":"2000","unstructured":"Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, Rudnicki MA (2000) Pax7 is required for the specification of myogenic satellite cells. Cell 102:777\u2013786 doi:S0092-8674(00)00066-0 [pii]","journal-title":"Cell"},{"key":"620_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mus.20665","volume":"35","author":"AE Slonim","year":"2007","unstructured":"Slonim AE, Bulone L, Goldberg T, Minikes J, Slonim E, Galanko J et al (2007) Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 35:70\u201377. \n                    https:\/\/doi.org\/10.1002\/mus.20665","journal-title":"Muscle Nerve"},{"key":"620_CR45","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1113\/expphysiol.2011.063313","volume":"97","author":"T Snijders","year":"2012","unstructured":"Snijders T, Verdijk LB, Beelen M, McKay BR, Parise G, Kadi F et al (2012) A single bout of exercise activates skeletal muscle satellite cells during subsequent overnight recovery. Exp Physiol 97:762\u2013773. \n                    https:\/\/doi.org\/10.1113\/expphysiol.2011.063313","journal-title":"Exp Physiol"},{"key":"620_CR46","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.15252\/embj.201488278","volume":"33","author":"AH Tang","year":"2014","unstructured":"Tang AH, Rando TA (2014) Induction of autophagy supports the bioenergetic demands of quiescent muscle stem cell activation. EMBO J 33:2782\u20132797","journal-title":"EMBO J"},{"key":"620_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ymgme.2011.05.013","volume":"104","author":"G Terzis","year":"2011","unstructured":"Terzis G, Dimopoulos F, Papadimas GK, Papadopoulos C, Spengos K, Fatouros I et al (2011) Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy. Mol Genet Metab 104:279\u2013283 doi:S1096-7192(11)00165-X [pii]10.1016\/j.ymgme.2011.05.013","journal-title":"Mol Genet Metab"},{"key":"620_CR48","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/labinvest.3700484","volume":"86","author":"BL Thurberg","year":"2006","unstructured":"Thurberg BL, Lynch Maloney C, Vaccaro C, Afonso K, Tsai AC-H, Bossen E et al (2006) Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease. Lab Invest 86:1208\u20131220","journal-title":"Lab Invest"},{"key":"620_CR49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nri.2016.150","volume":"17","author":"JG Tidball","year":"2017","unstructured":"Tidball JG (2017) Regulation of muscle growth and regeneration by the immune system. Nat Rev Immunol 17:165\u2013178","journal-title":"Nat Rev Immunol"},{"key":"620_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13023-015-0303-010.1186\/s13023-015-0303-0","volume":"10","author":"LE van den Berg","year":"2015","unstructured":"van den Berg LE, Favejee MM, Wens SC, Kruijshaar ME, Praet SF, Reuser AJ et al (2015) Safety and efficacy of exercise training in adults with Pompe disease: evalution of endurance, muscle strength and core stability before and after a 12 week training program. Orphanet J Rare Dis 10:87. \n                    https:\/\/doi.org\/10.1186\/s13023-015-0303-010.1186\/s13023-015-0303-0\n                    \n                   [pii]","journal-title":"Orphanet J Rare Dis"},{"key":"620_CR51","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","volume":"356","author":"H Van den Hout","year":"2000","unstructured":"Van den Hout H, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT (2000) Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 356:397\u2013398","journal-title":"Lancet"},{"key":"620_CR52","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HM van den Hout","year":"2003","unstructured":"van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT et al (2003) The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112:332\u2013340","journal-title":"Pediatrics"},{"key":"620_CR53","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","volume":"113","author":"JMP Van den Hout","year":"2004","unstructured":"Van den Hout JMP, Kamphoven JHJ, Winkel LPF, Arts WFM, De Klerk JBC, Loonen MCB et al (2004) Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics 113:e448\u2013e457","journal-title":"Pediatrics"},{"key":"620_CR54","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1750-1172-7-88","volume":"7","author":"NA van der Beek","year":"2012","unstructured":"van der Beek NA, de Vries JM, Hagemans ML, Hop WC, Kroos MA, Wokke JH et al (2012) Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. Orphanet J Rare Dis 7:88. \n                    https:\/\/doi.org\/10.1186\/1750-1172-7-88","journal-title":"Orphanet J Rare Dis"},{"key":"620_CR55","first-page":"82","volume":"106","author":"NAME van der Beek","year":"2006","unstructured":"van der Beek NAME, Hagemans MLC, van der Ploeg AT, Reuser AJJ, van Doorn PA (2006) Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy. Acta Neurol Belg. 106:82\u201386","journal-title":"Acta Neurol Belg."},{"key":"620_CR56","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ymgme.2016.05.013","volume":"119","author":"A van der Ploeg","year":"2016","unstructured":"van der Ploeg A, Carlier PG, Carlier RY, Kissel JT, Schoser B, Wenninger S et al (2016) Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study. Mol Genet Metab 119:115\u2013123","journal-title":"Mol Genet Metab"},{"key":"620_CR57","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT van der Ploeg","year":"2010","unstructured":"van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med 362:1396\u20131406","journal-title":"N Engl J Med"},{"key":"620_CR58","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0022-510X(87)90239-5","volume":"79","author":"AT van der Ploeg","year":"1987","unstructured":"van der Ploeg AT, Kroos M, van Dongen JM, Visser WJ, Bolhuis PA, Loonen MCB et al (1987) Breakdown of lysosomal glycogen in cultured fibroblasts from glycogenosis type II patients after uptake of acid \u03b1-glucosidase. J Neurol Sci 79:327\u2013336","journal-title":"J Neurol Sci"},{"key":"620_CR59","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT van der Ploeg","year":"2008","unstructured":"van der Ploeg AT, Reuser AJ (2008) Pompe\u2019s disease. The Lancet 372:1342\u20131353","journal-title":"The Lancet"},{"key":"620_CR60","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.stemcr.2018.04.002","volume":"10","author":"E van der Wal","year":"2018","unstructured":"van der Wal E, Herrero-Hernandez P, Wan R, Broeders M, In\u2019t Groen SLM, van Gestel TJM et al (2018) Large-Scale Expansion of Human iPSC-Derived Skeletal Muscle Cells for Disease Modeling and Cell-Based Therapeutic Strategies. Stem Cell Reports 10:1975\u20131990","journal-title":"Stem Cell Reports"},{"key":"620_CR61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.nmd.2012.09.003","volume":"23","author":"JV Wanschitz","year":"2013","unstructured":"Wanschitz JV, Dubourg O, Lacene E, Fischer MB, H\u00f6ftberger R, Budka H et al (2013) Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis. Neuromuscul Disord 23:75\u201383","journal-title":"Neuromuscul Disord"},{"key":"620_CR62","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1152\/physrev.00043.2011","volume":"93","author":"H Yin","year":"2013","unstructured":"Yin H, Price F, Rudnicki MA (2013) Satellite cells and the muscle stem cell niche. Physiol Rev 93:23\u201367. \n                    https:\/\/doi.org\/10.1152\/physrev.00043.2011","journal-title":"Physiol Rev"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0620-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0620-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0620-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:17:35Z","timestamp":1573067855000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0620-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,7]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0620-3","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,7]]},"assertion":[{"value":"17 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AvdP has provided consulting services for various industries in the field of Pompe disease under an agreement between these industries and Erasmus MC, Rotterdam, The Netherlands. The other authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"119"}}